POC diagnostics company Epocal gets $31mm via Series C
Executive Summary
Canadian diagnostics firm Epocal grossed $31mm through its Series C financing led by new investor Highland Capital Management, which was joined by other backers including Genesys Capital Partners, a returning shareholder. A member of Highland takes a seat on the company's board. Aquilo Partners acted as the placement agent.
Deal Industry
- In Vitro Diagnostics
- Medical Devices
-
In Vitro Diagnostics
- Biosensors
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice